Curricular
Seperating Faculties
Search for Curriculums
Bachelor’s Degree
Master’s Degree
Doctoral Degree
Other Curriculums
Studying at CMU
Application of Bachelor's Degree
Application for Graduate Studies
Application of International Program
CMU Presidential Scholarship
Faculties and Departments
Faculties
CMU’s Organizations
Other Division
News
Research and Innovation News
Outstanding News
Outstanding Staff
Prize and Pride
Conference and Seminar
Executives' News
Job Application
Procurement
Event Calendar
COVID-19 and PM2.5
Sports
Featured
Health
Laws and Regulations
Donations
Technology News
Religions
Journals
Articles on CMU 60 Years
About CMU
Background
Resolution/ Vision/ Mission/Values and Organizational Culture
Authority
CMU Corporate Identity
Organizational Structure and Administration of Chiang Mai University
Education Development Plan 5 years
Committee of University Council
Executives
Deans
Directors
Employee Council
Other related links
CMU First Year
CMU IT Life
Exchange Programs
Scholarships
Photo & News Archive
Open Data Integrity and Transparency Assessment : OIT
Privacy Policy
Contact
ภาษา
Thai
English
Chinese
TH
|
EN
|
CN
Home
News
News
Thai Probiotics-infused Milk Tablet’: a CMU Award-winning Solution to Help Tackle Metabolic Syndrome in Children
29 September 2025
Corporate Communication and Alumni Relations Center (CCARC)
Dr. Pattanapong Thoetthatha, from the Faculty of Agro-Industry at Chiang Mai University, has developed an innovative product known as the Thai Probiotics-Infused Milk Tablet, designed to help address metabolic syndrome in children. Metabolic syndrome is a cluster of conditions—including abdominal obesity, high blood sugar, and hypertension—that significantly increase the risk of obesity and type 2 diabetes later in life. This innovation was awarded a silver medal at the Higher Education Innovation Awards 2025, organized by the National Research Council of Thailand (NRCT).
The development of this product stems from the integration of two key technologies: a Thai probiotic strain, Lactiplantibacillus plantarum CMUB-N14, and resistant starch derived from sugar banana. The resistant starch serves a dual function—as a protective coating that enhances probiotic survival through the gastrointestinal tract, and as a prebiotic that supports beneficial gut microorganisms.
The research team found that gut microbiota varies according to genetics, geographical location, and dietary habits. As a result, the intestinal microbiota of Thai people differs from that of populations in other countries. A survey on probiotic consumption in Thailand revealed that approximately 90% of probiotics available in the market are imported, which may limit their effectiveness for Thai consumers. This finding motivated the development of a locally derived probiotic strain tailored to the Thai intestinal system.
Using sugar banana resistant starch as a coating allows the probiotics to survive digestion and reach the colon, where they can multiply and produce important metabolites such as short-chain fatty acids (SCFAs)—including acetic, propionic, and butyric acids—which play a key role in regulating metabolism. Additionally, the use of sugar banana enhances the nutritional value of the product while promoting the utilization of off-grade agricultural produce, thereby supporting local farmers.
Probiotics, which are beneficial microorganisms sourced from nature, have been shown to help address health concerns such as obesity and diabetes. In Thailand, the prevalence of metabolic syndrome among children is increasing, placing many at higher risk of abdominal obesity. Conventional approaches such as strict dietary control or medication may not be appropriate for children who are still in their growth stage.
To address this challenge, the research team incorporated the Thai probiotic strain into a milk tablet—a familiar and child-friendly snack—available in two flavors: original and chocolate. What distinguishes this product is its synbiotic formulation, combining probiotics with prebiotics from sugar banana starch to enhance the activity of beneficial intestinal microorganisms. While the primary target group is children, the product is also suitable for consumers of all age groups.
This innovation received a silver medal at the NRCT Higher Education Innovation Awards 2025 in the Agriculture and Agro-Industry category (Higher Education Track). Notably, the product was developed by first-year students under the guidance of their supervisor, reflecting the commitment to fostering entrepreneurship and startup development from an early stage of education. The technology also shows potential for application in other products, such as yogurt, functional beverages, and fermented foods including Naem (fermented ground pork).
Currently, L. plantarum CMUB-N14 is undergoing safety evaluation by BIOTEC for registration with the Food and Drug Administration (FDA), paving the way for future commercialization.
Outstanding Staff
Research and Innovation News
Awards and Recognition
Highlights
Gallery
×
RoomID:
Room Name:
Description: